¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chromosome set"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dicentric chromosome
    µÎ¸Åµì¿°»öü, ½Öµ¿¿øÃ¼¿°»öü
  • diploid chromosome
    µÎ¹è¼öü¿°»öü
  • homologous chromosome
    »óµ¿¿°»öü
  • inversion of chromosome
    ¿°»öüÀÚ¸®¹Ù²Þ
  • lampbrush chromosome
    ·¥ÇÁºê·¯½¬¿°»öü
  • mitochondrial chromosome
    »ç¸³Ã¼¿°»öü, ¹ÌÅäÄܵ帮¾Æ¿°»öü
  • monocentric chromosome
    Ȭ¸Åµì¿°»öü
  • mother chromosome
    ¾î¹Ì¿°»öü
  • meiotic chromosome
    °¨¼öºÐ¿­¿°»öü
  • metacentric chromosome
    Á߾Ӹŵ쿰»öü
  • nucleolar chromosome
    ÇÙ¼Òü¿°»öü
  • Philadelphia chromosome
    Çʶóµ¨ÇǾƿ°»öü
  • polycentric chromosome
    ´ÙÁ߽ɿ°»öü, ¹µ¸Åµì¿°»öü
  • recombinant chromosome
    ÀçÁ¶ÇÕ¿°»öü
  • ring chromosome
    °í¸®¿°»öü, À±»ó¿°»öü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dicentric chromosome
    ½ÖÁß½ÉÀý¿°»öü
  • diploid chromosome
    µÎ¹è¼ö¿°»öü
  • homologous chromosome
    »óµ¿¿°»öü
  • lampbrush chromosome
    ·¥ÇÁºê·¯½¬¿°»öü
  • manad chromosome
    ÀϺп°»öü
  • meiotic chromosome
    ¿°»öü³ª¼±, °¨¼öºÐ¿­¿°»öü
  • metacentric chromosome
    Á߾Ӹŵ쿰»öü
  • mitochondrial chromosome
    »ç¸³Ã¼¿°»öü
  • monocentric chromosome
    Ȭ¸Åµì¿°»öü
  • mother chromosome
    ¾î¹Ì¿°»öü
  • nucleolar chromosome
    ÇÙ¼Òü¿°»öü
  • Philadelphia chromosome
    Çʶóµ¨ÇǾƿ°»öü
  • polycentric chromosome
    ¹µ¸Åµì¿°»öü
  • ring chromosome
    °í¸®¿°»öü
  • satellite chromosome
    À§¼º¿°»öü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chromosome
    ¿°»öü
  • chromosome
    ¿°»öü(æøßäô÷)
  • chromosome
    ¿°»öü
  • chromosome 21
    ¿°»öü21
  • chromosome aberration
    ¿°»öüÀÌ»ó
  • chromosome abnormality
    ¿°»öü ÀÌ»ó(¡­ì¶ßÈ).
  • chromosome association
    ¿°»öüÁ¢ÇÕ(¡­ïÈùê).
  • chromosome breakage
    ¿°»öü¼Õ»ó
  • chromosome bridge
    ¿°»öü±³(¡­Îé).
  • chromosome chain
    ¿°»öü¼â(¡­áð).
  • chromosome configuration
    ¿°»öüÁ¢ÇÕÇü(¡­ïÈùêû¡).
  • chromosome imbalace
    ¿°»öüºÒ±ÕÇü
  • chromosome longarm deletion syndrome
    ¿°»öüÀåÁö°á¼ÕÁõÈıº(¡­íþò¦ÌÀáßñøý¦ÏØ).
  • chromosome map
    ¿°»öüÁöµµ (æøßäô÷ò¢Óñ).
  • chromosome matrix
    ¿°»öü±âÁú(¡­Ñ¨òõ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
POS periosteal osteosarcoma; physician order set; point of service; polycystic ovary syndrome; psychoorg...
PUMS patient utility measurement set; permanently unfit for military service
RISC reduced-instruction-set computer
SET surrogate embryo transfer; systolic ejection time
SET-N software evaluation tool for nursing
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FTDP-17 Frontotemporal dementia with Parkinsonism linked to chromosome 17
MAC mammalian artificial chromosome
MMCT Microcell-mediated chromosome transfer
MCM Mini-chromosome maintenance
PAC P-1 artificial chromosome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • rearrangement chromosome
    Àç¹è¿­ ¿°»öü
  • ring chromosome
    °í¸® ¿°»öü
  • salivary chromosome
    ħ»ù ¿°»öü
    °ïÃæÀÇ ½Ö½Ã·ù
  • univalent chromosome
    Ȭ¹è¼ö ¿°»öü
  • W-chromosome
    W ¿°»öü
  • X-chromosome
    X ¿°»öü
    »ç¶÷ÀÇ ¼º ¿°»öü·Î ¿©¼º¿¡¼­´Â XX, ³²¼º¿¡¼­´Â XY·Î Ç¥ÇöµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
chromosome 14 Trisomy 14 occurs de novo and is due to mosaicism. The distinct phenotype includes postnatal growth retardation, psychomotor retardation, prominent forehead, broad nose, dysmorphic ears, cleft or high arched palate, wide mouth, micrognathia, congenital heart disease, a short neck, asymmetry, abnormal skin pigmentation and hypertelorism.
Proximal 14 trisomy (14q1 trisomy) is almost always due to a malsegregation from a parental translocation. Growth and mental retardation are severe and the nose is prominent with broad nasal bridge, the upper lip is long with poorly defined philtrum, the mouth resembles the arc of a circle and the Cupid's bow is replaced by a medial notch. The commissures do not form an acute angle but are ovalised by the sagging of the external portions of the lower lip. Hypotelorism is present and anomalies of the limbs are frequent but longevity is generally not impaired.
14q32 trisomy shows macroglossia, mid-face hypoplasia, hypertelorism, umbilical hernia, hepatomegaly, cardiomegaly and moderately delayed psychomotor development. Seizures are reported.
Deletion 14(q11.1q13) is associated with hypotelorism, lack of nasal bridge, flattened nasal tip with no visible septum, wide midline cleft of lip and hard palate, ptosis of upper eyelid and semilobar holoprosencephaly. Ring chromosome 14 shows seizures, mild facial dysmorphism, developmental and moderate growth delay. Chromosome 14 carries the family of genes which encode the heavy chain of immunoglobulins.
(05 Mar 2000)
chromosome 15 Mosaic trisomy 15 is reported with no major or visible dysmorphia and severe inner organ defect. Duplication in the 15q11-13 region is also reported, although rarely, and can be associated with Prader-Willi syndrome. The phenotype includes developmental delay, particularly concerning acquisition of speech, ataxic gait with similarities to Angelman syndrome and seizures. Craniofacial dysmorphism includes oval face, high cheekbones and deep orbits. The trisomy can result from a malsegregation of a parental translocation, or can occur de novo with the presence of a supernumerary acrocentric chromosome of the size of a G-group chromosome or a supernumerary chromosome carrying satellites at both extremities. The latter rearrangement causes partial 15 tetrasomy results from an inverted duplication of chromosome 15. Patients with inv dup(15) show normal growth, moderate to severe mental retardation, seizures, poor motor coordination, behavioural problems, autism and mild dysmorphic features.
Triplication in the same 15q11-13 region is also reported. Clinically, the patients present with hypotonia, developmental delay, visual impairment and minor dysmorphic features. 15q2 trisomy results from malsegregation of a parental translocation and shows a highly characteristic craniofacial dysmorphism including microdolichocephaly, narrow palpebral fissures, protuberant philtral borders and micrognathia. Various osteoarticular anomalies are observed. Inner organ malformations include heart disease. Mental retardation is severe.
Prader-Willi syndrome and Angelman syndrome are distinct mental retardation disorders which result from paternal and maternal deficiency, respectively, for chromosome 15q11-q13. Approximately half of the patients with Prader-Willi syndrome show microscopically detectable paternally derived deletions, duplications and other chromosomal rearrangements of 15q11.2, or maternal uniparental disomy for chromosome 15. In contrast, Angelman syndrome can result from either maternally inherited deletions of this region or paternal uniparental disomy for chromosome 15. Major features of Prader-Willi syndrome include neonatal hypotonia with feeding difficulties, poor spontaneous movement, spells of cyanosis, a weak or absent cry, hypogonadism with cryptorchidism, mental retardation, obesity, hyperphagia and short stature. Features of Angelman syndrome include severe mental deficiency, ataxic (puppet-like) gait, prognathia and wide mouth, seizures and paroxysmal laughter.
The phenotype of an interstitial deletion 15q13 includes gross congenital anomalies consisting of large fontanelles and sutures, midface hypoplasia, flat ears with thin cartilage, prominent eyes, anteverted nostrils, cleft palate, positional deformation of hands and feet, hypertonia and inner organ malformations. The phenotype shows few overlapping features with Prader-Willi syndrome or Angelman syndrome.
Ring chromosome 15 is a rare cytogenetic disorder characterised by growth retardation, microcephaly, triangular facies, hypertelorism, brachydactyly, variable mental retardation and speech delay.
Gene assignments to chromosome 15 include the gene coding for hexosaminidase-A, whose mutation causes Tay-Sachs disease, and the major gene for Marfan syndrome.
(05 Mar 2000)
chromosome 16 Trisomy 16, the most common autosomal aneuploidy encountered in spontaneous abortuses, is rarely diagnosed in ongoing pregnancies and is considered lethal. However, cases of trisomy 16 mosaicism ascertained either by amniocentesis or in liveborn infants are reported. The liveborns exhibit a distinct and recognizable phenotype of highly variable severity, with multiple congenital anomalies and dysmorphic features including asymmetry, intrauterine growth retardation, congenital heart disease, respiratory tract and musculoskeletal defects.
The phenotype of 16p trisomy includes considerable intrauterine and postnatal growth retardation, small round skull, scant lashes and eyebrows, round flat face, prominent maxillae, micrognathia, round low-set ears with hypoplastic tragus and helix and protuberant anthelix, aplasia or hypoplasia of the thumb and severe mental impairment.
All reported cases of complete or partial duplication of 16q result from a parental translocation. Frequent findings include growth retardation, mental handicap, asymmetrical head, high forehead, short prominent or beaked nose, long philtrum and thin upper lip. Osteoarticular and perineal anomalies are constant.
Duplication 16q13 shows multiple malformations including ambiguous genitalia, congenital heart disease, syndactyly and unusual facies including downslanting palpebral fissures, low set ears with severe unilateral microtia, micrognathia and cleft palate.
Chromosome 16 gene assignments include the alpha-globin genes, whose mutations cause thalassaemias, and the genes for haptoglobin, adult polycystic kidney disease, and others.
(05 Mar 2000)
Chromosome 17 Chromosome 17 imbalances are not compatible with life. The phenotype of 17q2 trisomy, which is caused by a malsegregation of a parental translocation, includes microcephaly with high forehead, frontal bossing, high hairline with widow's peak, short thick neck, squinty eyes, large mouth with downturned corners, brachyrhizomelia, hexadactyly and severe mental retardation. Severe inner organ malformations are reported in patients with trisomy 17q23.
Charcot-Marie-Tooth is the most common peripheral neuropathy, occurring at a frequency of 1 in 2500. The most prevalent form of the disease, type 1 Charcot-Marie-Tooth , is characterised by significantly reduced nerve conduction velocities. The disease phenotype has been shown to segregate with a submicroscopic DNA duplication within 17p11.2, and Charcot-Marie-Tooth 1a patients are reported with cytogenetically visible duplication of 17p11.1-17p12. The disease phenotype is probably due to a gene dosage effect.
Miller-Dieker syndrome is comprised of a characteristic facial appearance and lissencephaly (smooth brain). Most Miller-Dieker syndrome patients have microdeletions of 17p13.3, detectable cytogenetically or submicroscopically.
Smith-Magenis syndrome is a clinically recognizable multiple congenital anomaly/MR syndrome associated with deletion of chromosome 17(p11.2). The patients show dysmorphic features including broad flat midface with brachycephaly, broad nasal bridge, brachydactyly, speech delay and hoarse deep voice, short stature, developmental delay and self- destructive behaviour, primarily onychotillomania and polyembolokoilamania, and sleep disturbances. Gene assignments include the p53 tumour suppressor, Charcot-Marie-Tooth type 1a,8 galactokinase and Niemann-Pick disease.
(05 Mar 2000)
chromosome 18 Edwards syndrome (trisomy 18), the second most common autosomal trisomy with an occurrence rate of 1 in 8,000 live births, is associated with a distinct pattern of dysmorphogenesis and congenital abnormalities which results in early death. Marked growth deficiency is a major trait of the phenotype. Other striking clinical features of this syndrome include congenital heart abnormalities, mental and developmental delays, prominent occiput, faunlike ears, micrognathia, short sternum, narrow pelvis, overlapping fingers and rocker-bottom feet. The 18q12.2 subband is identified as the critical region in the trisomy 18 phenotype. Trisomy 18 mosaicism can present with minimal non-specific signs and no typical stigmata of the full trisomy.
Although Edwards syndrome is typically associated with duplication of the entire chromosome 18, several individuals with partial trisomies of chromosome 18 (18q2 trisomy, 18p & q1 trisomy) are reported. These patients display a range of severity from a relatively mild phenotype with no internal organ malformations to the classic characteristics of Edwards syndrome.
Isochromosome 18p [i(18p)] is described 6 and is associated with a distinctive syndrome, tetrasomy 18p, which includes low birth weight, characteristic facies, neonatal hypotonia with subsequent limb spasticity, short stature, microcephaly, mental retardation and seizure disorders. Isochromosome 18q is a rare cytogenetic abnormality resulting in trisomy for the q arm and monosomy for the p arm of chromosome 18. Phenotypic characteristics are not yet fully delineated. Clinical and pathological examination reveals features characteristic of both trisomy 18 and monosomy 18p or features characteristic of trisomy 18 alone. Severe cephalic malformations such as holoprosencephaly, cebocephaly and cyclopia are reported in i(18q), but are rarely described in trisomy 18 and are only occasional findings in monosomy 18p. Isodicentric chromosome 18 was described and the clinical findings are associated with both the trisomy 18 and 18p- syndromes.
The 18q- syndrome or 18q2 monosomy is a well-described partial aneusomy disorder resulting from the deletion of a portion of the long arm of chromosome 18. Typically, patients with this syndrome show growth deficiency, dysmorphic facial features, limb defects, genitourinary malformations, neurologic and ocular anomalies, and developmental delay with mental retardation. The dysmorphic features are mild and include midfacial hypoplasia, carp-shaped mouth and abnormally folded ears. Neurologic findings consist of hypotonia, poor coordination, choreoathetotic movements and ophthalmologic abnormalities.
Proximal interstitial deletion of 18q involving band 18q12.3 is recognised with a distinctive phenotype including moderate to severe MR, high forehead, deep-set eyes, hypotelorism, flat nasal bridge, dysplastic ears, excess dermatoglyphic whorls and aggressive behaviour.
In the majority of deletions of the short arm of chromosome 18 (18p monosomy or 18p- syndrome), dysmorphism is not very distinctive. Psychomotor retardation is more or less severe. The ring 18 phenotype shares features of the 18p- syndrome and those of the 18q- syndrome with predominance of the features of the 18q monosomy. Mosaicism is frequently observed with ring chromosomes. The gene for peptidase A is localised to 18q23.
(05 Mar 2000)
chromosome 19 The phenotype of 19q trisomy, which is caused by malsegregation from familial translocation, includes microcephaly with brachycephaly, flat face, widely gaping cranial sutures, hypertelorism and palpebral ptosis, fishlike mouth, short neck, small pudgy hands and feet, growth retardation, slight to very severe mental retardation. Duplication of 19p13.1 and part of 19p13.2 is associated with developmental delay, unusual lower facial features including vertical ridging on the chin, extra philtral pillar, midline ridge on the anterior portion of the tongue and congenital heart defect. A placental karyotype of nonmosaic trisomy 19 was described with an abnormal foetus surviving to midtrimester.
Gene assignments on chromosome 19 include the gene for myotonic dystrophy at 19q13.3, Lewis and Lutheran blood groups and the chorionic gonadotrophin
chromosome 20 The phenotype of trisomy 20p, which results from a parental translocation, includes mild to moderate developmental delay, round face with telecanthus, flat nasal bridge and short palpebral fissures but major pre- and postnatal growth development malformations are rare. The phenotype of interstitial 20p deletion is consistent with Alagille syndrome, an autosomal dominant disease with reduced penetrance and variable expressivity, and is defined by bile duct paucity in association with cardiac, skeletal, ocular and facial abnormalities. 20q13 trisomy shows brachycephaly, hypertelorism, ear anomalies, cleft palate, micrognathia, chin dimple, anteverted nares, CNS malformations, heart defects, psychomotor retardation and reduced life expectancy. Ring chromosome 20 presents with absence of major congenital malformations and paucity of dysmorphic features. Patients can show behavioural problems, seizures, mild dysmorphic features and variable degrees of mental retardation. Sipple syndrome, or multiple endocrine neoplasia type 2, is assigned to chromosome 20p.
(05 Mar 2000)
chromosome 21 Down syndrome is the most common chromosome disorder seen in live births and is a leading cause of mental retardation. The frequency of the syndrome is estimated at 1 per 700 births and the risk increases exponentially with maternal age. Some of the manifestations are mental retardation, flat facies, oblique palpebral fissures, epicanthic folds, short broad hands, flattened occiput, cardiac abnormalities, hypotonia, Brushfield spots of the iris, abnormal dermatoglyphics, seizures, increased susceptibility to respiratory infections, increased incidence of leukaemia and premature ageing with Alzheimer-like brain degeneration.
92% to 95% of children born with Down syndrome have a free trisomy as a result of maternal nondisjunction (95%) or paternal nondisjunction (5%). Translocations account for the rest of the trisomies with t(14q21q) or t(15q2q) representing 54.2% of the cases, and t(21q21q) or t(21q22q)5 accounting for 40.9% of the cases. There are a few cases involving other chromosomes. In 55% of the cases, translocations involving the D group chromosomes arise de novo and in 45% of cases a parent carries the translocation. When a G group chromosome is involved t(21q21q) occurs 83.3% of the time. In the vast majority of cases t(21qGq) occurs de novo. Partial trisomy or tetrasomy 21 due to duplication of the distal segment 21q22 results in the classical Down phenotype. Partial trisomy of the proximal segment of 21q21 shows a fairly normal phenotype with moderate mental retardation. Monosomy-21 is not compatible with life. Deletions of chromosome 21 are associated with psychomotor and growth retardation, congenital heart disease, holoprosencephaly, microphthalmia, skeletal malformation, genital hypoplasia and other dysmorphisms.
Infants with ring chromosome 21 syndrome, a countertype of trisomy-21, show hypotonia, growth retardation, microcephaly and protruding occiput. Other malformations include ocular, cardiac, digestive, urogenital and skeletal malformation. Mental retardation is severe.
(05 Mar 2000)
chromosome 3p kinase <enzyme> Located in the small cell lung cancer tumour suppressor gene region; shows extensive homology to mitogen-activated protein kinase-activated protein kinase 2 (mapkap kinase 2); genbank u09578
Registry number: EC 2.7.10.-
Synonym: 3pk protein, 3pk gene product
(26 Jun 1999)
chromosome 8 Trisomy 8 mosaicism, one of the major cytogenetic syndromes, is characterised by a very suggestive facial dysmorphism, as well as osteoarticular anomalies.
Craniofacial dysmorphism includes long face, lop-ear deformities, prominent forehead and overhang of lower lip. Osteoarticular anomalies include camptodactyly, brachydactyly or arachnodactyly, clinodactyly, clubfoot and joint contractures leading to permanent deformities. Deep palmar and plantar creases can be noted in young infants. Skeletal malformations are frequent and severe. Inner organ malformations are rare and kidney or congenital heart defect can be observed. Mental deficiency is not very pronounced.
8p monosomy often occurs de novo. Patients present with a small skull with protruding occiput, short nose, small mouth, and a short and wide neck. Cardiac malformations are frequent. The degree of mental retardation is variable. Inverted duplications of chromosome 8p with distal deletion of 8p are reported.
Common clinical traits are hypotonia at birth, large mouth with thin upper lip, bulbous and broad nose, malformed ears, hand and feet anomalies and severe mental retardation. 8p trisomy can result from a parental translocation or can occur de novo. Patients have high prominent forehead, everted fleshy lower lip and flexion contractures of the limbs. Cardiac and cerebral malformations can be observed. Mental retardation is considerably more severe than with trisomy 8 mosaicism.
Mosaic tetrasomy 8p resulting from an isochromosome 8p was described. The clinical phenotype can overlap in part with those of trisomy 8 or trisomy 8p, but shows distinctive features including agenesis of the corpus callosum, cardiac malformations and minimal facial dysmorphism.
8q2 trisomy usually results from a parental translocation or inversion. The phenotype includes prominent forehead with hypertelorism, very wide bridge of the nose with blunt nasofrontal angle, microretrognathia, detached and poorly folded ears, buccal deformities including bifid tip of the tongue, cleft upper gum, high arched or cleft palate and bifid uvula. Joint contractures are also noted. Cardiac malformations are frequent and severe. Mental retardation is variable.
The Langer-Giedion syndrome, characterised by craniofacial dysmorphism and skeletal abnormalities, is caused by a genetic defect in 8q24.1. Among the gene assignments known for chromosome 8 is the gene for glutathione reductase, the deficiency of which causes a variety of haemolytic anaemia.
(05 Mar 2000)
chromosome 9 Trisomy 9 can be homogenous or mosaic. Microcephaly with dolichocephaly, enophthalmy and microretrognathia are present. Characteristic osteoarticular anomalies include dislocation of the hips, knees or elbows, deformities of the spinal cord and rib anomalies. Inner organ malformations involve cardiac, cerebral, renal and occasionally digestive anomalies. The prognosis is most severe.
The 9p monosomy syndrome is characterised by trigonocephaly, long upper lip with undefined philtral borders, short nose, anteverted nares, psychomotor retardation, upward slant of palpebral fissures, dolichomesophalangy. Malformations are severe. The majority of the cases occur de novo, or can result from a parental translocation. 9p trisomy was the first partial trisomy identified before the use of banding techniques and is probably one of the most frequently detected. The majority of pure 9p trisomies occur de novo. In 9q trisomy and associated 9p trisomy, malsegregation of a parental rearrangement is always involved. Craniofacial dysmorphism includes brachycephaly, bulbous nose and short upper lip with a very characteristic asymmetric grin when the mouth opens. The knit brows, slanted palpebral fissures and mouth give a particularly distinctive worried look. The palms are long in comparison with the fingers. A single palmar crease is constant. Malformations are rare in cases of pure 9p trisomy but they are numerous and diverse in cases of associated 9p trisomy. Mental retardation is variable. Life expectancy is not impaired.
Tetrasomy 9p is remarkable due to the infrequency of autosomal tetrasomies. The phenotype is variable and the facial dysmorphism can resemble that of 9p trisomy. Malformations are severe and numerous. Homogeneous tetrasomies lead to early death. Mosaicism appears to diminish the severity of the outlook.
9q32 trisomy shows dolichocephaly, deep set eyes with short palpebral fissures, large poorly folded ears, beaked nose, marked microretrognathia, long abnormally implanted fingers and toes and severe developmental delay. Inner organ malformations involve the heart. The trisomy results from a tandem duplication arising de novo or from malsegregation of a parental rearrangement. Interstitial deletion 9q22-q32 is reported with multiple congenital anomalies.
The phenotype of ring chromosome 9 is variable and the principal features of 9p monosomy can be observed, as well as certain malformations seen in trisomy 9.
Some major genes on chromosome 9 are those for the ABO blood group, fibroblast and leukocyte interferons, familial dysautonomia, Friedreich ataxia, nail-patella syndrome and galactose-1-phosphate uridyltransferase, whose deficiency causes galactosaemia.
(05 Mar 2000)
chromosome aberration Any deviation from the normal number or morphology of chromosomes; also the phenotypic consequences thereof.
(05 Mar 2000)
chromosome aberrations Deviations from the normal number or structure of chromosomes, not necessarily associated with disease.
(12 Dec 1998)
chromosome abnormalities Defects in the structure or number of chromosomes resulting in structural aberrations or manifesting as disease.
(12 Dec 1998)
chromosome band A region of darker or contrasting staining across the width of a chromosome; the pattern of band's is characteristic for most chromosomes.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • dead set
    »ç³É°³°¡ »ç³É°¨À» °¡¸®Å°´Â ºÎµ¿ÀÇ ÀÚ¼¼;¸Í°ø°Ý;²öÁú±ä ³ë·Â
  • dresser set
    È­Àå µµ±¸ ¼¼Æ®(ºø,°Å¿ï µî)
  • empty set
    (¼ö)°øÁýÇÕ
  • fuzzy set
    È帲 ÁýÇÕ(¸íÈ®È÷ Á¤ÀÇµÈ °æ°è¸¦ °¡ÁöÁö ¾ÊÀº ÁýÇÕ)
  • indexed sequential data set
    (Àü»ê)»öÀÎ ¼øÂ÷ µ¥ÀÌŸ ¼¼Æ®
  • love set
    ÆÐÀÚ°¡ ÇÑ °ÔÀÓµµ µûÁö ¸øÇÑ ¼¼Æ®
  • nail set
    (¸ñ¼öÀÇ)¸ø¹Ú´Â±â±¸
  • null set
    °øÁýÇÕ(¿ø¼Ò¸¦ Çϳªµµ Æ÷ÇÔÄ¡ ¾Ê´Â ÁýÇÕ)
  • radio receiver(receiving set)
    ¶óµð¿À ¼ö½Å±â
  • receiving set
    ¼ö½Å(¼ö»ó)±â
  • set
    µÎ´Ù;ÇâÇÏ´Ù;°íÁ¤½ÃŰ´Ù;±»¾îÁö´Ù;Á¾»çÇÏ´Ù;½ñ´Ù;(µÀÀ»)¿Ã¸®´Ù;(ºÒÀ»)ºÙÀÌ´Ù;(°ªÀ»)¸Å±â´Ù;(¸ð¹üÀ»)º¸ÀÌ´Ù;(»À¸¦)ÀÕ´Ù;(½Ã°è¸¦)¸ÂÃß´Ù;°íÁ¤½ÃŰ´Ù;(¸Ó¸®Ä®À»)±æµéÀÌ´Ù;ÀáÀç¿ì´Ù;Á¾»ç½ÃŰ´Ù;ÁýÁßÇÏ´Ù;Á¤ÇÏ´Ù;¾à¼ÓÇÏ´Ù
  • set piece
    ¼Òǰ
  • set point
    ¼¼Æ® Æ÷ÀÎÆ®(¼¼Æ®ÀÇ ½ÂÆÐ¸¦ Á¤ÇÏ´Â ÇÑ Á¡)
  • set scene
    ¹«´ë ÀåÄ¡
  • set square
    »ï°¢ÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á